Han Wang

The prevalence of HLA‐I LOH in Chinese pan‐cancer patients and genomic features of patients harboring HLA‐I LOH

Y. Guan, Xiaorui Fu, Zeyi Liu, 2021, Human mutation.

RBM10 Deficiency Is Associated With Increased Immune Activity in Lung Adenocarcinoma

X. Yi, Xin Yang, Shi Yan, 2021, Frontiers in Oncology.

The efficacy and safety of neoadjuvant anti-PD-1 inhibitor combined with platinum-based chemotherapy in patients with potentially resectable non-small cell lung cancer.

Y. Guan, L. Zeng, N. Yang, 2021 .

Immune checkpoint inhibitors for brain metastases in non-small-cell lung cancer: from rationale to clinical application.

R. Zhou, Haiqin Peng, Zhiyuan Liu, 2021, Immunotherapy.

The prevalence of HLA‐I LOH in Chinese pan‐cancer patients and genomic features of patients harboring HLA‐I LOH

Y. Guan, Xiaorui Fu, Zeyi Liu, 2021, Human mutation.